Approvals/CIMA-AEMPS/OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA ALEMBIC 40 MG/10 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Approved

STANDARD

OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA ALEMBIC 40 MG/10 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Alembic Pharmaceuticals Europe Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: a013ce36c6278106
Drug Cima Aemps Name: OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA ALEMBIC 40 MG/10 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number: 85888
Holder Company Name: Alembic Pharmaceuticals Europe Limited
Marketing Company Name: Alembic Pharmaceuticals Europe Limited
Authorization Date: 2021-03-31
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 40 mg/10 mg/25 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Alembic Pharmaceuticals Europe Limited

OLMESARTAN MEDOXOMILO

40 mg

AMLODIPINO BESILATO

13.9 mg

HIDROCLOROTIAZIDA

25 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Mar 31, 2021

Approval ID

a013ce36c6278106

Type

Standard